United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - letermovir (unii: 1h09y5wo1f) (letermovir - unii:1h09y5wo1f) - letermovir 240 mg - prevymis® is indicated for prophylaxis of cytomegalovirus (cmv) infection and disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant. prevymis is indicated for prophylaxis of cmv disease in adult kidney transplant recipients at high risk (donor cmv seropositive/recipient cmv seronegative [d+/r-]). - prevymis is contraindicated in patients receiving pimozide or ergot alkaloids: pimozide: concomitant administration of prevymis in patients receiving pimozide may result in increased concentrations of pimozide due to inhibition of cytochrome p450 3a (cyp3a) by letermovir, which may lead to qt prolongation and torsades de pointes [see warnings and precautions (5.1) and drug interactions (7.2, 7.3)] . ergot alkaloids: concomitant administration of prevymis in patients receiving ergot alkaloids may result in increased concentrations of ergot alkaloids (ergotamine and dihydroergotamine) due to inhibition of cyp3a by letermovir, which may lead to ergotism [see war

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; carnauba wax; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; iron oxide red - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydroxypropylbetadex - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - tablet, film coated - excipient ingredients: carnauba wax; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; povidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - injection, concentrated - excipient ingredients: water for injections; hydroxypropylbetadex; sodium chloride; sodium hydroxide - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - letermovir - cytomegalovirus infections - antivirals for systemic use - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - letermovir - film coated tablets - letermovir 240 mg - letermovir - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - letermovir - film coated tablets - letermovir 480 mg - letermovir - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

Canada - English - Health Canada

merck canada inc - letermovir - solution - 20mg - letermovir 20mg - hiv protease inhibitors

Canada - English - Health Canada

merck canada inc - letermovir - solution - 20mg - letermovir 20mg - hiv protease inhibitors